Allen GO

No ORCID on file · 3 papers in corpus
observational 2005
Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer
Obstetrics and gynecology ·doi:10.1097/01.aog.0000154152.12088.48

OBJECTIVE: Oral contraceptives (OCs) have been consistently linked to reduced risk of ovarian cancer. Oral contraceptive formulations display varying degrees of androgenicity. Data linking androgens to ovarian cancer suggest that OC androge…

other 2004
Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2004.03.035

OBJECTIVE: Women with endometriosis may be at an increased risk of ovarian cancer. It is not known whether reproductive factors that reduce the risk of ovarian cancer in general also reduce risk in women with endometriosis. We investigated …

observational 2003
Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer
Clinical cancer research : an official journal of the American Association for Cancer Research

PURPOSE: It has been hypothesized that circulating androgens may be involved in the development of ovarian cancer. The androgenic medication, danazol, and the antiandrogenic medications, leuprolide and nafarelin, are commonly used in the tr…